ArticleCurrent medical mycology2018
Antifungal effects of ethanolic and aqueous extracts of
Article in Current medical mycology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- The efficacy and safety of current treatment of vulvovaginal candidiasis: An umbrella review of systematic reviews and meta-analyses.Naunyn-Schmiedeberg's archives of pharmacology · 2025Pooled it
- Review
- WildMolecules (Basel, Switzerland) · 2023Article
- Antifungal Resistance of ClinicalIranian journal of public health · 2023Review
- Evaluation of Anti-Evidence-based complementary and alternative medicine : eCAM · 2023Article
- Profiling of Antifungal Activities and In Silico Studies of Natural Polyphenols from Some Plants.Molecules (Basel, Switzerland) · 2021Article
- In vitro anticandidal activity and gas chromatography-mass spectrometry (GC-MS) screening ofPeerJ · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeVulvovaginal candidiasis is one of the most common infections in female genital organs, which is caused by MATERIALS AND
methodsGas chromatography-mass spectrometry analysis was performed on vitex to identify its possible bioactive components. Forty
resultsThe major chemical components of vitex leaf as determined by gas chromatography included α-Pinene, isoterpinolene, caryophyllene, and azulene. The minimum inhibitory concentrations (MICs) of aqueous and alcoholic extracts of vitex, as well as fluconazole were within the ranges of 15.62-62.5, 7.81-15.62, and 0.25-8 μg/mL, respectively.
conclusionOur findings showed that the alcoholic and aqueous extracts of vitex had antifungal activity against clinical isolates of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.